Schizophrenia genomics and proteomics: are we any closer to biomarker discovery?
2009
Schizophrenia Genomics and Proteomics: Progress Towards Biomarker Discovery
publication
Evidence: moderate
Author Information
Author(s): Lakhan Shaheen E, Kramer Alon
Primary Institution: Global Neuroscience Initiative Foundation, Los Angeles, CA, USA
Hypothesis
Can biological markers be identified for schizophrenia through genomics and proteomics?
Conclusion
While significant progress has been made in schizophrenia biomarker research, no definitive biomarkers have been discovered yet.
Supporting Evidence
- Over 2 million people in the US are affected by schizophrenia.
- Recent studies show cerebrospinal fluid may hold potential biomarkers.
- Genetic studies have identified candidate genes linked to schizophrenia.
- International cooperation is enhancing research efforts in schizophrenia.
Takeaway
Scientists are trying to find special markers in the body that can help diagnose schizophrenia, but they haven't found any good ones yet.
Methodology
The review summarizes recent studies in genomics and proteomics related to schizophrenia biomarkers.
Limitations
The review highlights the need for larger studies and better standardization in biomarker research.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website